One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
NCT ID: NCT02983123
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1750 participants
OBSERVATIONAL
2016-11-15
2018-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Safety of a Clinical Assessment and 0h/1h Troponin Rule-Out Protocol
NCT03421873
Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study
NCT03489603
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
NCT03668587
Troponin to Risk Stratify Patients for Computed Tomography Coronary Angiography
NCT04549805
TnThs Predicting Evolving Non-STEMI
NCT00953251
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All recruited patients will have serial troponins drawn at 0, 1- and 4/6 hours, with the main hypothesis that the absolute changes within 1 hour can be used as surrogates for the changes and conclusions drawn after 4/6 hours. The cut-off levels used within the 0/1-hour algorithm are assay specific as specified in the 2015 European Society of Cardiology Guidelines for the management of acute NSTEMI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 hour-troponin
1-hour troponin collected of all recruited patients in addition to the daily routine with serial troponins collected at 0- and 4/6 hours.
1-hour hs-cTnT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1-hour hs-cTnT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
Exclusion Criteria
* Strong suspicion of an acute NSTEMI/unstable angina (directly to the hospital)
* Terminal kidney disease with a glomerular filtration rate (GFR) \< 30
* Unable to communicate in Norwegian, Swedish, Danish or English language
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dan Atar
Professor of Cardiology and Head of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Atar, MD, PhD
Role: STUDY_DIRECTOR
Oslo University Hospital and University of Oslo, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo Accident and Emergency Outpatient Clinic
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Johannessen TR, Melessen IMB, Vallersnes OM, Manten A, Halvorsen S, Atar D, Harskamp RE. Adequately identifying low-risk chest pain in emergency primary care: evaluating the performance of preHEAR(T) based on two European cohorts. Open Heart. 2025 Jul 27;12(2):e003362. doi: 10.1136/openhrt-2025-003362.
Johannessen TR, Halvorsen S, Atar D, Vallersnes OM. Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population. J Am Heart Assoc. 2022 Apr 5;11(7):e024927. doi: 10.1161/JAHA.121.024927. Epub 2022 Mar 30. No abstract available.
Johannessen TR, Atar D, Vallersnes OM, Larstorp ACK, Mdala I, Halvorsen S. Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study. BMJ Open. 2021 Feb 24;11(2):e046024. doi: 10.1136/bmjopen-2020-046024.
Johannessen TR, Vallersnes OM, Halvorsen S, Larstorp ACK, Mdala I, Atar D. Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study. Open Heart. 2020 Jul;7(2):e001296. doi: 10.1136/openhrt-2020-001296.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/13308
Identifier Type: OTHER
Identifier Source: secondary_id
2016/1241/REK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.